Griesinger; Christian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Griesinger; Christian.The latest application filed is for "phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma".

Company Profile

3.10.8

Griesinger; Christian - Gottingen DE
Griesinger; Christian - Goettingen DE
Griesinger; Christian - Oberursel DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma Grant 11,180,518 - Becker , et al. November 23, 2	2021-11-23
Phenyl-heterocycle-phenyl Derivatives For Use In The Treatment Or Prevention Of Melanoma App 20200165279 - BECKER; Dorothea ; et al.	2020-05-28
Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases Grant 10,435,373 - Giese , et al. O	2019-10-08
Water-soluble derivatives of 3,5-diphenyl-diazole compounds Grant 10,308,671 - Giese , et al.	2019-06-04
Water-soluble Derivatives Of 3,5-diphenyl-diazole Compounds App 20180370997 - GIESE; Armin ; et al.	2018-12-27
Drug For Inhibiting Aggregation Of Proteins Involved In Diseases Linked To Protein Aggregation And/or Neurodegenerative Diseases App 20180346426 - GIESE; Armin ; et al.	2018-12-06
Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases Grant 10,071,966 - Giese , et al. September 11, 2	2018-09-11
Drug For Inhibiting Aggregation Of Proteins Involved In Diseases Linked To Protein Aggregation And/or Neurodegenerative Diseases App 20160185730 - Giese; Armin ; et al.	2016-06-30
Mutant alpha-synuclein, and methods using same Grant 9,253,964 - Zweckstetter , et al. February 9, 2	2016-02-09
Transgenic non-human animal comprising a mutant alpha-synuclein Grant 9,247,721 - Zweckstetter , et al. February 2, 2	2016-02-02
Mutant Alpha-Synuclein, and Methods Using Same App 20150143556 - ZWECKSTETTER; Markus ; et al.	2015-05-21
Mutant Alpha-Synuclein, and Methods Using Same App 20150125951 - ZWECKSTETTER; Markus ; et al.	2015-05-07
Mutant alpha-synuclein, and methods using same Grant 8,809,505 - Zweckstetter , et al. August 19, 2	2014-08-19
Mutant Alpha-Synuclein, and Methods Using Same App 20110296539 - Zweckstetter; Markus ; et al.	2011-12-01
New Drug For Inhibiting Aggregation Of Proteins Involved In Diseases Linked To Protein Aggregation And/or Neurodegenerative Diseases App 20110293520 - Giese; Armin ; et al.	2011-12-01
Tetrapeptides as antitumor agents Grant 5,939,527 - Barlozzari , et al. August 17, 1	1999-08-17
Pentapeptides as antitumor agents Grant 5,741,892 - Barlozzari , et al. April 21, 1	1998-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.